Enzyme

The global infrastructure for tokenized finance

London, United Kingdom · Founded 2016 · $2.9M raised

Headquarters
London
Employees
11–50
Founded
2016
Business Model
B2B
Total Funding
$2.9M
Last Round
$2.9M Equity CrowdfundingFeb 2017
Rounds
1

About

Enzyme is a decentralized finance protocol and infrastructure platform providing institutional-grade tools for tokenized fund issuance, on-chain asset management, and financial instrument creation across Ethereum and Canton networks. Originally launched as Melon Protocol in 2016, Enzyme empowers asset managers, fund issuers, portfolio managers, and financial service providers to build, operate, and administer tokenized hedge funds, money market funds, structured products, and on-chain options. The platform has processed over $7 billion in total transaction volume with more than $200 million in assets under technology and operates with a track record of zero security breaches across 8+ years.

Summary

Enzyme is a Crypto & Web3 company based in London, United Kingdom, founded in 2016. It has raised $2.9M in total across 1 round, most recently a $2.9M Equity Crowdfunding round in Feb 2017.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Equity CrowdfundingCrowdfundingFeb 2017
$2.9M

Similar Companies